Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Dearnaley

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
The Lancet. Oncology|May 4, 2023
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocolGerhardt Attard, Laura Murphy, Noel W Clarke, et al.
JNCI Cancer Spectrum|July 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled TrialNicholas D James, Fiona C Ingleby, Noel W Clarke, et al.
International Journal of Cancer|April 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)Nicholas D James, Noel W Clarke, Adrian Cook, et al.
JNCI Cancer Spectrum|October 20, 2023
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer typesElnaz Naderi, Miguel E Aguado-Barrera, Line M H Schack, et al.
Nature Genetics|September 22, 2009
Identification of seven new prostate cancer susceptibility loci through a genome-wide association studyRosalind A Eeles, Zsofia Kote-Jarai, Ali Amin Al Olama, et al.
Nature Genetics|July 12, 2011
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyZsofia Kote-Jarai, Ali Amin Al Olama, Graham G Giles, et al.
Human Molecular Genetics|October 16, 2012
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive diseaseAli Amin Al Olama, Zsofia Kote-Jarai, Fredrick R Schumacher, et al.
Nature Genetics|March 29, 2013
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping arrayRosalind A Eeles, Ali Amin Al Olama, Sara Benlloch, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
The Lancet. Oncology|May 4, 2023
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocolGerhardt Attard, Laura Murphy, Noel W Clarke, et al.
JNCI Cancer Spectrum|July 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled TrialNicholas D James, Fiona C Ingleby, Noel W Clarke, et al.
International Journal of Cancer|April 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)Nicholas D James, Noel W Clarke, Adrian Cook, et al.
JNCI Cancer Spectrum|October 20, 2023
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer typesElnaz Naderi, Miguel E Aguado-Barrera, Line M H Schack, et al.
Nature Genetics|September 22, 2009
Identification of seven new prostate cancer susceptibility loci through a genome-wide association studyRosalind A Eeles, Zsofia Kote-Jarai, Ali Amin Al Olama, et al.
Nature Genetics|July 12, 2011
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyZsofia Kote-Jarai, Ali Amin Al Olama, Graham G Giles, et al.
Human Molecular Genetics|October 16, 2012
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive diseaseAli Amin Al Olama, Zsofia Kote-Jarai, Fredrick R Schumacher, et al.
Nature Genetics|March 29, 2013
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping arrayRosalind A Eeles, Ali Amin Al Olama, Sara Benlloch, et al.
Pageof 15